Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03874637 · ClinicalTrials.gov registry record · NA
FemPulse Therapy First-in-Human Experience
A NA study, sponsored by FemPulse Corporation.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT03874637 is a NA study that has completed, run by FemPulse Corporation. The registered enrollment target is 15 participants.
The verdict
NCT03874637, a NA study, has completed, sponsored by FemPulse Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this clinical trial is to investigate a new medical device treatment for Overactive Bladder (OAB) in women.
Interventions
- DEVICE Sham Control
- DEVICE Treament
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2017-02-14 |
| Est. Completion | 2017-05-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03874637
The ClinicalTrials.gov registry entry for NCT03874637 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is FemPulse Corporation, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham Control is the first listed.
NCT03874637 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03874637 about?
NCT03874637 is a clinical study titled "FemPulse Therapy First-in-Human Experience". The purpose of this clinical trial is to investigate a new medical device treatment for Overactive Bladder (OAB) in women.
What is the current status of trial NCT03874637?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2017-02-14. Estimated completion is 2017-05-17.
What interventions are being tested in trial NCT03874637?
The interventions under investigation include: Sham Control (DEVICE), Treament (DEVICE).
Who is sponsoring clinical trial NCT03874637?
This trial is sponsored by FemPulse Corporation, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.